Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 32% ± 13% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 11% | |
GABAergic neuron | 4 studies | 38% ± 17% | |
retina horizontal cell | 4 studies | 28% ± 9% | |
interneuron | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 29% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 60% | 221.68 | 1587 / 2642 | 12% | 0.26 | 88 / 705 |
prostate | 63% | 27.32 | 155 / 245 | 1% | 0.11 | 4 / 502 |
blood vessel | 63% | 102.97 | 839 / 1335 | 0% | 0 | 0 / 0 |
bladder | 52% | 60.52 | 11 / 21 | 0% | 0 | 0 / 504 |
intestine | 35% | 26.70 | 341 / 966 | 0% | 0 | 0 / 527 |
adrenal gland | 10% | 11.57 | 27 / 258 | 23% | 1.88 | 52 / 230 |
stomach | 32% | 12.90 | 114 / 359 | 0% | 0 | 0 / 286 |
kidney | 19% | 5.74 | 17 / 89 | 0% | 0.00 | 1 / 901 |
breast | 18% | 6.63 | 81 / 459 | 0% | 0.00 | 1 / 1118 |
thymus | 13% | 4.17 | 85 / 653 | 0% | 0 | 0 / 605 |
lung | 12% | 4.15 | 72 / 578 | 0% | 0.00 | 1 / 1155 |
esophagus | 7% | 3.56 | 104 / 1445 | 0% | 0 | 0 / 183 |
adipose | 7% | 2.18 | 84 / 1204 | 0% | 0 | 0 / 0 |
ovary | 7% | 1.86 | 12 / 180 | 0% | 0 | 0 / 430 |
heart | 3% | 0.83 | 22 / 861 | 0% | 0 | 0 / 0 |
skin | 2% | 0.74 | 43 / 1809 | 0% | 0 | 0 / 472 |
uterus | 1% | 0.19 | 1 / 170 | 0% | 0 | 0 / 459 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 1 / 178 |
spleen | 0% | 0.08 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.04 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | PCDH11Y |
Protein name | Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22) Protocadherin 11 Y-linked |
Synonyms | PCDHY PCDH11 PCDH22 |
Description | FUNCTION: Potential calcium-dependent cell-adhesion protein. FUNCTION: Potential calcium-dependent cell-adhesion protein. . |
Accessions | ENST00000333703.8 [Q9BZA8-3] ENST00000400457.3 [Q9BZA8-1] ENST00000698851.1 ENST00000621505.1 ENST00000698927.1 A0A087WUC5 ENST00000215473.7 [Q9BZA8-4] A0A8V8TMG2 ENST00000362095.9 [Q9BZA8-2] ENST00000622698.4 [Q9BZA8-3] Q9BZA8 A0A8V8TP37 |